Advanced Search
Contact | Corporate | Help

Rituximab + Immune Globulin Intravenous (IVIG) for Desensitization

Sponsors:
  • Cedars-Sinai Medical Center
  • Genentech
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Kidney Transplantation
Age Groups:
  • Adult
Gender:
Both
Names:
  • Biological: Rituxan
Enrollment:
90

Additional information about NCT01178216.


SourceSolution © 2008-2012